GlassScriptPhysician profile
Troy D Brooks
NPI 1447364898
$1,110.17
in general payments reported to CMS, 2019-2025
18 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.96 · 2022: $201 · 2023: $269 · 2024: $252 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $164.84 | 2024-2025 | Farxiga, Airsupra |
| Abbott Laboratories | $148.88 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $138.89 | 2023-2025 | Jardiance, Zepbound, Mounjaro |
| Novo Nordisk INC | $124.36 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.17 | 2022-2024 | Jardiance |
| Glaxosmithkline, LLC. | $70.48 | 2023-2024 | Trelegy Ellipta, Bexsero, Arexvy |
| Abbvie INC. | $69.87 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $62.06 | 2022 | |
| Pfizer INC. | $56.92 | 2022-2024 | |
| Exact Sciences Corporation | $33.27 | 2024-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $26.75 | 2023 | |
| Esperion Therapeutics, INC. | $26.17 | 2021 | |
| Corium, LLC | $24.31 | 2022 | |
| Shield Therapeutics INC | $20.20 | 2024 | |
| Hologic Sales and Service, LLC | $17.86 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $17.76 | 2023 | Austedo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.99 | 2025 | Caplyta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.